Search

everythinglearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.